Last reviewed · How we verify

NCT07482124: MEASURE

Multicenter Registry of Patients With Subarachnoid Hemorrhage

Recruiting now Last updated 19 March 2026
What this trial tests

trial testing None, observational study in Subarachnoid Hemorrhage, Spontaneous in 1,000 participants. Currently enrolling.

Timeline
12 February 2024
Primary endpoint
1 August 2026
1 February 2028

Quick facts

Lead sponsorUMC Utrecht
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,000
Start date12 February 2024
Primary completion1 August 2026
Estimated completion1 February 2028
Sites9 locations across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

UMC Utrecht — full company profile →

Who can join

Eligibility, any sex, with Subarachnoid Hemorrhage, Spontaneous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage. This information will enable research aimed at improving the safety and effectiveness of current and future treatments. By studying these data, the investigators aim to identify which treatment strategies offer the best results and which factors are most important in the care of patients with a subarachnoid hemorrhage. The knowledge gained from this research will help improve patient care in the future.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of None, observational study

Trials testing the same drug.

Other recruiting trials for Subarachnoid Hemorrhage, Spontaneous

Currently open trials in the same condition.

Other UMC Utrecht trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07482124.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing